Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

Healthcare Medical Devices
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

iCAD Reports Financial Results for First Quarter Ended March 31, 2022

GlobeNewswire May 11, 2022

iCAD's "ProFound Insights, ProFound Impact" Webinar Series to Feature Clinical and IT Experts from Wake Radiology

GlobeNewswire April 28, 2022

iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11

GlobeNewswire April 27, 2022

iCAD Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems

GlobeNewswire April 26, 2022

iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions

GlobeNewswire April 21, 2022

iCAD Launches ProFound Insights, ProFound Impact Webinar Series on April 27

GlobeNewswire April 19, 2022

iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment

GlobeNewswire April 5, 2022

iCAD Highlights Breast Health AI Platform at the 2022 Healthcare Information and Management Systems Society (HIMSS) Meeting

GlobeNewswire March 14, 2022

iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference

GlobeNewswire March 10, 2022

iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference

GlobeNewswire March 9, 2022

iCAD Among the First to Validate its AI Cancer Detection Solutions with the NVIDIA AI Enterprise Software Suite

GlobeNewswire March 2, 2022

iCAD to Present at the 42nd Annual Cowen Health Care Conference

GlobeNewswire March 1, 2022

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021

GlobeNewswire February 28, 2022

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

GlobeNewswire February 14, 2022

iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 8, 2022

iCAD's Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

GlobeNewswire January 24, 2022

iCAD Announces the Appointment of New Members to its Board of Directors

GlobeNewswire January 11, 2022

iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues

GlobeNewswire January 4, 2022

iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event

GlobeNewswire December 23, 2021

First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States

GlobeNewswire December 14, 2021